Navigating the Emerging and Evolving Landscape of HER2-Low Breast Cancer

Download All

Learn more about HER2 testing and emerging treatment options for patients with HER2-low breast cancer.

For additional education and resources on HER2-low breast cancer, including online modules, podcasts, and downloadable slides, visit ASCP’s website at https://www.ascp.org/content/learning/breast-cancer.

Sara Hurvitz, MD, FACP

ClinicalThought

What I want my colleagues to know about distinguishing patients with HER2-low breast cancer and emerging data on potential treatment options.

Sara Hurvitz, MD, FACP Released: March 24, 2022
Provided by the American Society for Clinical Pathology, in partnership with Q Synthesis LLC and Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

 
Supported by educational grants from
AstraZeneca
Daiichi Sankyo, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings